VA

VR Adviser Portfolio holdings

AUM $1.33B
This Quarter Return
+10.12%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$369M
AUM Growth
–
Cap. Flow
+$369M
Cap. Flow %
100%
Top 10 Hldgs %
90.12%
Holding
16
New
16
Increased
–
Reduced
–
Closed
–

Top Buys

1
CNST
Constellation Pharmaceuticals, Inc.
CNST
$126M
2
AXSM icon
Axsome Therapeutics
AXSM
$47.7M
3
RLMD icon
Relmada Therapeutics
RLMD
$28.7M
4
TRIL
Trillium Therapeutics Inc.
TRIL
$27.4M
5
ETNB icon
89bio
ETNB
$24M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 88.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$126M 34.2% +4,016,873 New +$126M
AXSM icon
2
Axsome Therapeutics
AXSM
$6.05B
$47.7M 12.91% +810,000 New +$47.7M
RLMD icon
3
Relmada Therapeutics
RLMD
$37.2M
$28.7M 7.79% +842,814 New +$28.7M
TRIL
4
DELISTED
Trillium Therapeutics Inc.
TRIL
$27.4M 7.43% +6,790,000 New +$27.4M
ETNB icon
5
89bio
ETNB
$1.34B
$24M 6.51% +952,200 New +$24M
INO icon
6
Inovio Pharmaceuticals
INO
$126M
$21.6M 5.84% +2,900,000 New +$21.6M
TXG icon
7
10x Genomics
TXG
$1.74B
$18.7M 5.06% +300,000 New +$18.7M
MRSN icon
8
Mersana Therapeutics
MRSN
$36.5M
$15.3M 4.14% +2,623,903 New +$15.3M
MRNS
9
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$13.2M 3.58% +6,502,840 New +$13.2M
VSTM icon
10
Verastem
VSTM
$569M
$9.82M 2.66% +3,720,930 New +$9.82M
ADVM icon
11
Adverum Biotechnologies
ADVM
$64.6M
$9.72M 2.63% +994,381 New +$9.72M
ISEE
12
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$8.9M 2.41% +2,586,537 New +$8.9M
AVDL
13
Avadel Pharmaceuticals
AVDL
$1.43B
$8.4M 2.28% +1,057,827 New +$8.4M
SRRA
14
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4.82M 1.31% +491,017 New +$4.82M
SPRO icon
15
Spero Therapeutics
SPRO
$116M
$3.83M 1.04% +474,015 New +$3.83M
PTGX icon
16
Protagonist Therapeutics
PTGX
$3.67B
$799K 0.22% +113,140 New +$799K